Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients
NCT03874026
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
34
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
ADCC
Interventions
DRUG:
Folfiri/Cetuximab
Sponsor
National Cancer Institute, Naples